Accuracy of Valproic Acid Concentration Correction Based on Serum Albumin
- PMID: 30328046
- DOI: 10.1007/s12028-018-0627-4
Accuracy of Valproic Acid Concentration Correction Based on Serum Albumin
Abstract
Background: Patient-specific factors can alter the pharmacokinetic disposition of valproic acid. Specifically, the free fraction of valproic acid can increase substantially in patients with hypoalbuminemia or as serum drug concentrations rise due to saturable protein binding. Direct measurement of free serum drug concentrations allows for accurate assessment of drug levels, but the assay may not be readily available in all institutions. The effect of hypoalbuminemia on free fraction has been quantified and serves as the basis of an equation used to "correct" measured total valproic acid concentrations. The aim of this study was to evaluate the accuracy of the equation.
Methods: This retrospective study included adult patients with measurable free and total valproic acid concentrations between July 2014 and June 2017. The primary aim was to assess the relationship between measured and predicted free valproic acid concentrations. Free levels were categorized as subtherapeutic, therapeutic, or supratherapeutic based on the reference range of 7-23 mg/L. Concordance was defined as measured and predicted concentrations falling within the same category.
Results: The analysis included 174 patients with a median age of 58 years and a median albumin of 3 g/dL. The majority of patients were hospitalized (88.5%). Concordance occurred in 56.9% of samples. A Spearman's correlation coefficient of 0.60 (p < 0.001) was found between the measured and predicted free valproic acid concentrations. Concordance of concentrations was 42% for ICU patients, 63% for floor patients, and 65% for outpatients. Of those with discordant concentrations, 97% of the predicted concentrations underestimated the measured concentrations.
Conclusions: There is discordance between predicted and measured free serum valproic acid concentrations when using the proposed equation. Because of the potential impact of underestimation and variability of free valproic acid concentrations, a measured free level is the ideal option for therapeutic drug monitoring of valproic acid.
Keywords: Free fraction; Hypoalbuminemia; Pharmacokinetics; Valproic acid.
Similar articles
-
A theoretical method for normalizing total serum valproic acid concentration in hypoalbuminemic patients.J Pharmacol Sci. 2005 Apr;97(4):489-93. doi: 10.1254/jphs.fpe04007x. J Pharmacol Sci. 2005. PMID: 15840952
-
Prediction of Serum-Free and Cerebrospinal Fluid Valproic Acid Levels in Patients With Hypoalbuminemia After Craniotomy.Ther Drug Monit. 2020 Aug;42(4):610-616. doi: 10.1097/FTD.0000000000000749. Ther Drug Monit. 2020. PMID: 32106182
-
Comparison of free fraction serum valproic acid concentrations between inpatients and outpatients.Am J Health Syst Pharm. 2015 Jan 15;72(2):121-6. doi: 10.2146/ajhp140191. Am J Health Syst Pharm. 2015. PMID: 25550135
-
Valproate Protein Binding Is Highly Variable in ICU Patients and Not Predicted by Total Serum Concentrations: A Case Series and Literature Review.Pharmacotherapy. 2017 Apr;37(4):500-508. doi: 10.1002/phar.1912. Epub 2017 Mar 16. Pharmacotherapy. 2017. PMID: 28173638 Review.
-
Clinical Pharmacokinetic Monitoring of Free Valproic Acid Levels: A Systematic Review.Clin Pharmacokinet. 2022 Oct;61(10):1345-1363. doi: 10.1007/s40262-022-01171-w. Epub 2022 Aug 30. Clin Pharmacokinet. 2022. PMID: 36040614
Cited by
-
Design and validation of a predictive equation to estimate unbound valproic acid concentration.Eur J Hosp Pharm. 2023 Sep;30(5):293-296. doi: 10.1136/ejhpharm-2021-003092. Epub 2021 Nov 8. Eur J Hosp Pharm. 2023. PMID: 34750247 Free PMC article. Clinical Trial.
-
Derivation and Validation of a New Equation for Estimating Free Valproate Concentration in Critically Ill Adult Patients.Crit Care Explor. 2023 Oct 18;5(10):e0987. doi: 10.1097/CCE.0000000000000987. eCollection 2023 Oct. Crit Care Explor. 2023. PMID: 37868026 Free PMC article.
-
Monitoring of the trough concentration of valproic acid in pediatric epilepsy patients: a machine learning-based ensemble model.Front Pharmacol. 2024 Dec 18;15:1521932. doi: 10.3389/fphar.2024.1521932. eCollection 2024. Front Pharmacol. 2024. PMID: 39744128 Free PMC article.
-
Therapeutic drug monitoring for valproate: deriving a novel formula for calculation of free concentration.Eur J Clin Pharmacol. 2024 Nov;80(11):1751-1759. doi: 10.1007/s00228-024-03741-2. Epub 2024 Aug 16. Eur J Clin Pharmacol. 2024. PMID: 39150536 Free PMC article.
-
CYP2C9*3/*3 Gene Expression Affects the Total and Free Concentrations of Valproic Acid in Pediatric Patients with Epilepsy.Pharmgenomics Pers Med. 2021 Apr 9;14:417-430. doi: 10.2147/PGPM.S301893. eCollection 2021. Pharmgenomics Pers Med. 2021. PMID: 33859491 Free PMC article.
References
-
- Valproic Acid [package insert]. Upsher-Smith Laboratories,Inc., Maple Grove, MN. 2016.
-
- Goldenberg MM. Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment. P&T. 2010;35:392–415.
-
- Hilal-Dandan R, Brunton LL. Pharmacotherapy of the epilepsies. In: Goodman and Gilman’s manual of pharmacology and therapeutics, 2nd edn. New York: McGraw-Hill Education; 2016.
-
- Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia. Intern Emerg Med. 2012;7(Suppl 3):S193–9. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources